Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2024-11-29
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: €1.56 M
• Last year FTD volume: €1.56 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Merck MRK	€24.78 M	€98.35 M	🇺🇸 USA
SIGA Technologies SIGA	€0.98 M	€6.66 M	🇺🇸 USA
GlaxoSmithKline GSK	€57.35 M	€99.79 M	🇬🇧 UK
Celldex Therapeutics CLDX	€1.22 M	€6.08 M	🇺🇸 USA
Pfizer PFE	€48.65 M	€0.35 B	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	€14.55 M	€40.99 M	🇮🇱 Israel
Soligenix SNGX	N/A	€5.6 M	🇺🇸 USA